OVERALL SAFETY PROFILE OF BOCEPREVIR (BOC) PLUS PEGINTERFERON ALFA-2A/RIBAVIRIN IN GENOTYPE 1 PREVIOUS NON-RESPONDERS AND RELAPSERS TO PEGINTERFERON/RIBAVIRIN

被引：0

作者：

Flamm, Steven L. ^{[1
]}

Lawitz, Eric ^{[2
]}

Jacobson, Ira M. ^{[3
]}

Bourliere, Marc ^{[4
]}

Hezode, Christophe ^{[5
]}

Vierling, John M. ^{[6
]}

Niederau, Claus ^{[7
]}

Sherman, Morris ^{[8
]}

Bacon, Bruce R. ^{[9
]}

Pedicone, Lisa ^{[10
]}

Goteti, Venkata S. ^{[10
]}

Burroughs, Margaret ^{[10
]}

Brass, Clifford A. ^{[10
]}

Albrecht, Janice K. ^{[10
]}

Poordad, F. Fred ^{[11
]}

机构：

[1] NW Feinberg Sch Med, Chicago, IL USA

[2] Alamo Med Res, San Antonio, TX USA

[3] Weill Cornell Med Coll, New York, NY USA

[4] Fdn Hop St Joseph, Marseille, France

[5] Hop Henri Mondor, APH Paris, F-94010 Creteil, France

[6] Baylor Coll Med, Houston, TX 77030 USA

[7] St Josef Hosp, Oberhausen, Germany

[8] Toronto Gen Hosp, Toronto, ON, Canada

[9] St Louis Univ, Sch Med, St Louis, MO USA

[10] Merck Sharp & Dohme Corp, Whitehouse Stn, NJ USA

[11] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：838A / 838A

页数：1